BCAX (NASDAQ: BCAX) issuer to sell 5,500 shares; insider sales disclosed

Rhea-AI Filing Summary

BCAX reports an issuer-related planned sale of 5,500 common shares tied to an exercise of stock options to be effected on 03/25/2026 for cash. The filing also discloses recent open-market sales by David Raben: 200 shares on 03/03/2026 for $3,690.00 and 16,300 shares on 03/04/2026 for $301,920.01.

Insights

Equity Markets Analyst

Issuer plans a 5,500-share sale tied to option exercise; recent insider sales are disclosed.

The filing shows an exercise of stock options resulting in the issuer offering 5,500 common shares on 03/25/2026, with proceeds described as cash. Recent dispositions by David Raben total 16,500 shares across two trades in early March.

Cash‑flow treatment is stated as cash for the issuer sale; further details on pricing or use of proceeds are not included in the excerpt.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	UBS Financial Services Inc. 11 Madison Avenue 4th Floor New York NY 10010	5500	104229.40	54781950	03/25/2026	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/25/2026	Exercise of Stock Options	Issuer			5500	03/25/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
David Raben 116 HUNTINGTON AVENUE SUITE 703 BOSTON MA 02116	Common	03/03/2026	200	3690.00
David Raben 116 Huntington Avenue Suite 703 Boston MA 02116	Common	03/04/2026	16300	301920.01

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the BCAX Form 144 disclose about the 5,500 shares?

The Form 144 discloses an exercise of stock options that will result in the issuer offering 5,500 common shares on 03/25/2026, with the transaction described as for cash.

Who sold shares recently according to the filing for BCAX?

The filing lists sales by David Raben: 200 shares sold on 03/03/2026 for $3,690.00 and 16,300 shares sold on 03/04/2026 for $301,920.01.

Does the Form 144 state how the issuer will use proceeds from the 5,500 shares?

The Form 144 describes the issuer sale as resulting from an exercise of stock options and notes proceeds as cash; the excerpt does not specify any uses of proceeds or allocation details.

When will the issuer sale linked to the option exercise occur for BCAX?

The issuer-related sale tied to the option exercise is scheduled to be effected on 03/25/2026, as explicitly stated in the filing excerpt.